Systems analysis of human vaccine adjuvants

被引:39
|
作者
Harandi, Ali M. [1 ]
机构
[1] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden
关键词
Vaccine; Adjuvant; Vaccinology; Systems vaccinology; Omics; Transcriptomics; MOLECULAR SIGNATURES; SEASONAL INFLUENZA; TUBERCULOSIS; IMMUNOGENICITY; INFLAMMASOME; RESPONSES; BIOLOGY; ALUM; MF59;
D O I
10.1016/j.smim.2018.08.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The discovery and wide spread use of vaccines have saved millions of lives in the past few decades. Vaccine adjuvants represent an integral part of the modem vaccines. Despite numerous efforts, however, only a handful of vaccine adjuvants is currently available for human use. A comprehensive understanding of the mechanisms of action of adjuvants is pivotal to harness the potential of existing and new adjuvants in mounting desirable immune responses to counter human pathogens. Decomposing the host response to vaccines and its components at systems level has recently been made possible owing to the recent advancements in Omics technology and cutting edge immunological assays powered by systems biology approaches. This approach has begun to shed light on the molecular signatures of several human vaccines and adjuvants. This review is an attempt to provide an overview of the recent efforts in systems analysis of vaccine adjuvants that are currently in clinic.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 50 条
  • [1] Molecular signatures of vaccine adjuvants
    Olafsdottir, Thorunn
    Lindqvist, Madelene
    Harandi, Ali M.
    VACCINE, 2015, 33 (40) : 5302 - 5307
  • [2] Vaccine adjuvants: mode of action
    De Gregorio, Ennio
    Caproni, Elena
    Ulmer, Jeffrey B.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [3] Trends in vaccine adjuvants
    Schijns, Virgil E. J. C.
    Lavelle, Ed C.
    EXPERT REVIEW OF VACCINES, 2011, 10 (04) : 539 - 550
  • [4] Liposomes as immunological adjuvants and delivery systems in the development of tuberculosis vaccine: A review
    Luwi, NurEllene Mat
    Ahmad, Suhana
    Azlyna, AhmadSuhaimi Nurfatihah
    Nordin, Asyikin
    Sarmiento, MariaElena
    Acosta, Armando
    Azmi, MohdNor
    Uskokovie, Vuk
    Mohamud, Rohimah
    Kadir, Ramlah
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (01) : 7 - 16
  • [5] Vaccine adjuvants: Why and how
    Christensen, Dennis
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2709 - 2711
  • [6] Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
    Reinke, Soeren
    Thakur, Aneesh
    Gartlan, Cillian
    Bezbradica, Jelena S.
    Milicic, Anita
    VACCINES, 2020, 8 (03) : 1 - 25
  • [7] Mechanism of action of licensed vaccine adjuvants
    Tritto, Elaine
    Mosca, Flaviana
    De Gregorio, Ennio
    VACCINE, 2009, 27 (25-26) : 3331 - 3334
  • [8] Neonatal vaccine effectiveness and the role of adjuvants
    Sakala, Isaac G.
    Eichinger, Katherine Marie
    Petrovsky, Nikolai
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) : 869 - 878
  • [9] Biomaterials as vaccine adjuvants
    Jones, Kim S.
    BIOTECHNOLOGY PROGRESS, 2008, 24 (04) : 807 - 814
  • [10] Vaccine adjuvants: A priority for vaccine research
    Harandi, Ali M.
    Medaglini, Donata
    Shattock, Robin J.
    VACCINE, 2010, 28 (12) : 2363 - 2366